UBS Group’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $244M | Buy |
9,910,822
+1,338,765
| +16% | +$31M | 0.03% | 559 |
|
|
2026
Q1 | $205M | Sell |
8,572,057
-100,787
| -1% | -$2.46M | 0.03% | 606 |
|
|
2025
Q4 | $196M | Sell |
8,672,844
-7,795,304
| -47% | -$170M | 0.03% | 584 |
|
|
2025
Q3 | $332M | Buy |
16,468,148
+5,961,457
| +57% | +$99.9M | 0.05% | 356 |
|
|
2025
Q2 | $150M | Buy |
10,506,691
+6,066,677
| +137% | +$70.9M | 0.03% | 688 |
|
|
2025
Q1 | $46.6M | Buy |
4,440,014
+274,735
| +7% | +$3.11M | 0.01% | 1541 |
|
|
2024
Q4 | $50.4M | Buy |
4,165,279
+2,294,012
| +123% | +$30M | 0.01% | 1457 |
|
|
2024
Q3 | $27.5M | Sell |
1,871,267
-40,394
| -2% | -$563K | 0.01% | 1578 |
|
|
2024
Q2 | $27.6M | Buy |
1,911,661
+718,850
| +60% | +$11.5M | 0.01% | 1432 |
|
|
2024
Q1 | $19.4M | Buy |
1,192,811
+75,615
| +7% | +$1.18M | ﹤0.01% | 1715 |
|
|
2023
Q4 | $16.6M | Buy |
1,117,196
+435,291
| +64% | +$4.93M | 0.01% | 1714 |
|
|
2023
Q3 | $7.66M | Buy |
681,905
+299,166
| +78% | +$3.47M | ﹤0.01% | 2196 |
|
|
2023
Q2 | $3.85M | Buy |
382,739
+155,203
| +68% | +$1.44M | ﹤0.01% | 2839 |
|
|
2023
Q1 | $2.14M | Sell |
227,536
-341,402
| -60% | -$4.03M | ﹤0.01% | 3360 |
|
|
2022
Q4 | $6.95M | Buy |
568,938
+373,337
| +191% | +$4.65M | ﹤0.01% | 2194 |
|
|
2022
Q3 | $2.43M | Buy |
195,601
+28,134
| +17% | +$492K | ﹤0.01% | 2988 |
|
|
2022
Q2 | $3.29M | Sell |
167,467
-51,138
| -23% | -$1.21M | ﹤0.01% | 2721 |
|
|
2022
Q1 | $5.7M | Sell |
218,605
-37,234
| -15% | -$992K | ﹤0.01% | 2414 |
|
|
2021
Q4 | $7.26M | Sell |
255,839
-1,433,714
| -85% | -$44.6M | ﹤0.01% | 2445 |
|
|
2021
Q3 | $53.9M | Buy |
1,689,553
+490,239
| +41% | +$16.4M | 0.02% | 827 |
|
|
2021
Q2 | $41.6M | Buy |
1,199,314
+384,875
| +47% | +$12.7M | 0.01% | 968 |
|
|
2021
Q1 | $24M | Buy |
814,439
+220,771
| +37% | +$6.79M | 0.01% | 1315 |
|
|
2020
Q4 | $18.2M | Sell |
593,668
-12,057,629
| -95% | -$368M | 0.01% | 1402 |
|
|
2020
Q3 | $353M | Buy |
12,651,297
+1,604,867
| +15% | +$40.7M | 0.13% | 161 |
|
|
2020
Q2 | $237M | Buy |
11,046,430
+10,598,327
| +2,365% | +$234M | 0.1% | 211 |
|
|
2020
Q1 | $10M | Sell |
448,103
-183,090
| -29% | -$5.01M | ﹤0.01% | 1411 |
|
|
2019
Q4 | $18.6M | Buy |
631,193
+190,657
| +43% | +$5.18M | 0.01% | 1434 |
|
|
2019
Q3 | $11.7M | Sell |
440,536
-285,826
| -39% | -$8.57M | ﹤0.01% | 1644 |
|
|
2019
Q2 | $24.6M | Buy |
726,362
+318,787
| +78% | +$10.3M | 0.01% | 1065 |
|
|
2019
Q1 | $13.1M | Buy |
407,575
+399,949
| +5,245% | +$12.3M | 0.01% | 1461 |
|
|
2018
Q4 | $241K | Sell |
7,626
-1,142
| -13% | -$37.4K | ﹤0.01% | 4825 |
|
|
2018
Q3 | $306K | Buy |
+8,768
| New | +$308K | ﹤0.01% | 4744 |
|
Other funds holding ELAN
UBS Group's ELAN Position: Q2 2026 in Review
UBS Group increased its Elanco Animal Health (ELAN) stake by 16% in Q2 2026, buying an estimated $31M and bringing the position to 9,910,822 shares worth $244M. The position accounts for 0.03% of the portfolio, ranked #559.
UBS Group first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $353M in Q3 2020. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- UBS Group held 9,910,822 shares of Elanco Animal Health worth $244M as of Q2 2026.
- UBS Group bought 1,338,765 Elanco Animal Health shares in Q2 2026, an estimated $31M.
- Elanco Animal Health made up 0.03% of UBS Group's portfolio in Q2 2026, its #559 holding.
- UBS Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
- UBS Group's Elanco Animal Health position peaked at $353M in Q3 2020.
- 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.